Skip to content

Scholar Rock SRRK Enterprise value

Enterprise value at other companies

Biogen logo
BiogenBIIB
$30.08B+34.9%
Edgewise Therapeutics, Inc. logo
Edgewise Therapeutics, Inc.EWTX
$3.35B+63.5%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$5.2B+77.3%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$2.41B+228%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$2.27B-4.1%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$6.02B+951%

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$5.67B+85.5%

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Calculated from Scholar Rock’s reported figures.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's enterprise value?
Scholar Rock (SRRK) reported enterprise value of $5.42B in Q1 2026.
How has Scholar Rock's enterprise value changed year-over-year?
Scholar Rock's enterprise value increased by 82.6% year-over-year, from $2.97B to $5.42B.
What is the long-term trend for Scholar Rock's enterprise value?
Over 5 years (2020 to 2025), Scholar Rock's enterprise value has grown at a 21.7% compound annual growth rate (CAGR), from $1.6B to $4.28B.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.